HDAC1 and glioblastoma: In laboratory assays, we confirmed that Paromomycin interacts specifically with and modulates SUMOylated HDAC1 protein, resulting in a significant reduction in GBM cell growth, motility, and invasiveness (Fox et al., 2019; Cheng et al., 2023; Guo et al., 2022).